TITLE

Clinical and Virological Course of Chronic Hepatitis B Virus Infection With Hepatitis C and D Virus Markers

AUTHOR(S)
Yun-Fan Liaw; Sun-Lung Tsai; I-Shyan Sheen; Mei Chao; Chau-Ting Yeh; Sen-Yung Hsieh; Chia-Ming Chu
PUB. DATE
March 1998
SOURCE
American Journal of Gastroenterology;Mar1998, Vol. 93 Issue 3, p354
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Hepatitis B, C, and delta virus (HBV, HCV, HDV) share similar transmission routes; thus, dual or triple infections may occur and even persist in the same patient. However, little is known about the presentations and course of chronic HBV infection with HCV and HDV markers, which this study examined. Methods: Antibodies against HCV (anti-HCV) and HDV (anti-HDV) were assayed as appropriate in patients with HBV infection. The clinical, pathological, and virological presentations as well as the course of the disease in patients with HBV/HDV/HCV triple infection markers were then reviewed. Results: A total of 60 patients, 51 men and nine women, age 19-67 yr (mean 45.9 ± 1.6 yr) were identified. Of these 60 patients, five (8.3%) were HBeAg positive and 10 (16.7%) cirrhotic at entry, 30 (50%) presented with acute superinfection (HCV or HDV, or both) and the remaining 30 presented with chronic liver disease. On presentation, 16 (53.3%) of the 30 patients with acute superinfection showed hepatic decompensation and eight (26.7%) died. In contrast, only one of the patients with "chronic liver disease" presented with hepatic decompensation. Of the 42 patients followed up for 1-15 (mean, 4.7 ± 0.6) yr, 45.2% showed remission and 19% showed HBsAg seroclearance, whereas 12.5% of the 32 noncirrhotics developed cirrhosis and three of the nine cirrhotics became decompensated. At the end of follow-up, 29 patients (69.9%) were still seropositive for HCV-RNA but only nine (22.5%) were seropositive for HDV-RNA and five (12.5%) were seropositive for HBV-DNA. Conclusions: These results suggest that infection with HBV, HCV, and HDV triple markers is a severe disease in acute superinfection stage but that the course is relatively benign, slowly progressive, and usually dominated by HCV.
ACCESSION #
16019009

 

Related Articles

  • Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Cortes-Mancera, Fabian; Loureiro, Carmen Luisa; Hoyos, Sergio; Restrepo, Juan-Carlos; Correa, Gonzalo; Jaramillo, Sergio; Norder, Helene; Pujol, Flor Helene; Navas, Maria-Cristina // Hepatitis Research & Treatment;2011, p1 

    Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end-stage liver diseases in the world. A study was carried out on end-stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia....

  • Extrahepatic Manifestations of Chronic Viral Hepatitis. Willson, Richard A. // American Journal of Gastroenterology;Jan1997, Vol. 92 Issue 1, p4 

    Presents a clinical review of the established extra-hepatic associations with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Relationship of HBV infection with systemic necrotizing vasculitis or polyarteritis nodosa; Description of the association between chronic HBV...

  • Genes Determining the Course of Virus Persistence in the Liver: Lessons from Murine Infection with Lymphocytic Choriomeningitis Virus. Lang, Philipp A.; Recher, Mike; Häussinger, Dieter; Lang, Karl S. // Cellular Physiology & Biochemistry (Karger AG);2010, Vol. 26 Issue 3, p263 

    More than 500 million people worldwide are persistently infected with either hepatitis B virus (HBV) or hepatitis C virus (HCV). Although both viruses are poorly cytopathic, persistent infection causes severe immunopathologic damage to liver tissue; histologically, such damage is characterized...

  • Hepatitis C, the Quiet Epidemic. Martin, Justin // Fortune;8/7/1995, Vol. 132 Issue 3, p29 

    Reports on the spread of the hepatitis C virus in the United States. How hepatitis C has been increasing by 150,000 new cases annually in the United States; Famous people who suffer from the virus, including Mickey Mantle and Naomi Judd; How hepatitis B has reached epidemic proportions in Asia;...

  • Editorial: Recent advances in HBV and HCV immunology. Dustin, Lynn B.; Trehanpati, Nirupma; Smith, Kendall Arthur // Frontiers in Immunology;Sep2015, p1 

    The author discusses recent reports in hepatitis B virus (HVB) and hepatitis C virus (HCV) immunology on topics including availability of prophylactic vaccine for HBV, lifelong therapy for curing HBV infection and liver inflammation due to untreated HBV and HCV.

  • Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Crockett, Seth D; Keeffe, Emmet B // Annals of Clinical Microbiology & Antimicrobials;2005, Vol. 4, p13 

    Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is not uncommon as a result of similar routes of infection. Patients who are coinfected represent a unique group with diverse serologic profiles. Combined chronic hepatitis B and C leads to more severe liver disease and an increased...

  • No Detected Hepatitis B Virus-DNA in Thalassemic Patients Infected by Hepatitis C Virus in Kerman Province in Iran. Arababadi, Mohammad Kazemi; Hassanshahi, Gholamhossein; Yousefi, Hassan; Zarandi, Ebrahim Rezazadeh; Moradi, Mohammad; Mahmoodi, Mahdi // Pakistan Journal of Biological Sciences;2008, Vol. 11 Issue 13, p1738 

    This research was aimed to investigate the prevalence and clinical impact of occult HBV infection in thalassemic patients with chronic HCV infection. In this cross-sectional study we have totally examined 60 patients suffering HBV and HCV infections by PCR and RT-PCR methods, respectively, in...

  • Modulation of Tumor Necrosis Factor Receptors 1 and 2 in Chronic Hepatitis B and C: The Differences and Implications in Pathogenesis. Dar-In Tai; Sun-Lung Tsai, Philip K.; Tse-Ching Chen, Philip K.; Sing Kai Lo; Ya-Hui Chang, Philip K.; Yun-Fan Liaw // Journal of Biomedical Science;2001, Vol. 8 Issue 4, p321 

    Tumor necrosis factor (TNF) plays a role in the pathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC). The difference in the cytokine responses between hepatitis B virus (HBV) and hepatitis C virus (HCV) infections may have implications in the pathogenesis of these diseases. We...

  • Silent, Dangerous and Spreading. Miller, Doriane // Chicago Citizen - South Suburban Edition;7/25/2012, Vol. 31 Issue 38, p2 

    The article discusses the risks of Hepatitis C. There are three strains of the Hepatitis virus, A, B, and C. These strains all cause inflammation to the liver. It states that the most common form is Hepatitis A which is usually caused by food or water contaminated with fecal matter and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics